FIRST AMENDMENT TO THE SUPPLY AND MARKETING AGREEMENT BETWEEN PENTECH PHARMACEUTICALS, INC. AND PAR PHARMACEUTICAL, INC.Supply and Marketing Agreement • March 28th, 2003 • Pharmaceutical Resources Inc • Pharmaceutical preparations
AMENDMENT NO. 1 TO SUPPLY AND MARKETING AGREEMENTSupply and Marketing Agreement • March 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
This Amendment No. 1 to Supply and Marketing Agreement (this “Amendment”) is entered into on the 18th day of December, 2009 by and between Aristos Pharmaceuticals, Inc., a Delaware corporation with its principal offices located at 1255 Crescent Green Drive, Suite 250, Cary, NC 27518 (“ARISTOS”), and Sovereign Pharmaceuticals, Ltd., a Texas limited partnership with its principal offices located at 7590 Sand Street, Fort Worth, TX, 76118 (“SOVEREIGN”), and shall be effective as of the 30th day of September, 2009.
SUPPLY AND MARKETING AGREEMENTSupply and Marketing Agreement • May 4th, 2021
RECITALS:Supply and Marketing Agreement • November 15th, 2004 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • California
SUPPLY AND MARKETING AGREEMENT BETWEEN PENTECH PHARMACEUTICALS, INC. AND PAR PHARMACEUTICAL, INC.Supply and Marketing Agreement • January 11th, 2002 • Pharmaceutical Resources Inc • Pharmaceutical preparations • New York
SUPPLY AND MARKETING AGREEMENTSupply and Marketing Agreement • August 16th, 2022
PETS CORNER SDN BHDSupply and Marketing Agreement • August 21st, 2013
This Agreement made on the date of between PETS CORNER SDN BHD (Company No: 123637-H), a company incorporated in Malaysia with limited liability and addressed at No.8, Jalan Tun Razak, 50400 Kuala Lumpur, Malaysia (hereinafter referred to as “the Company” ) and (Company
Supply And Marketing Agreement Parties Clarins Cosmetics (Shanghai) Company LimitedSupply and Marketing Agreement • April 28th, 2023 • Able View Global Inc. • Retail-nonstore retailers
MASTER DEVELOPMENT, MANUFACTURING, SUPPLY AND MARKETING AGREEMENT BY AND BETWEEN PUREPAC PHARMACEUTICAL CO. ( A WHOLLY OWNED SUBSIDIARY OF ALPHARMA INC.) AND ORCHID CHEMICALS & PHARMACEUTICALS LTD. EFFECTIVE FEBRUARY 23, 2005Supply and Marketing Agreement • March 31st, 2005 • Alpharma Inc • Pharmaceutical preparations • New York
This MASTER DEVELOPMENT, MANUFACTURING, SUPPLY AND MARKETING AGREEMENT (this "Agreement") is entered into as of 23 February 2005 (the "Effective Date"), by and between Purepac Pharmaceutical Co, a corporation organized and existing under the laws of Delaware, US ("Alpharma"), a wholly owned subsidiary of Alpharma Inc. and Alpharma Inc., a corporation organized and existing under the laws of Delaware, US ("Alpharma Inc."), solely with regards to the guarantee in Section 14.14 and Orchid Chemicals & Pharmaceuticals, Ltd., a corporation organized and existing under the laws of India ("Orchid").
